Direct Fed Microbial Market by Product Type (Lactic Acid Bacteria, Bacillus, and Others) and Livestock (Swine, Poultry, Ruminants Aquatic Animals, and Others):Global Opportunity Analysis and Industry Forecast, 2019–2026
The global direct fed microbial market was valued at $980 million in 2018 and is expected to reach $1,772 million by 2026, registering a CAGR of 7.5% from 2019 to 2026.
Direct-fed microbial or probiotics are live microorganisms that are beneficial to the gut health. These probiotics are included in the diet of animals to promote their growth and development. In addition, they help to boost the immune system of animals, and thus prevent the growth of pathogenic organisms in the gut. The use of probiotic organisms is replacing antibiotic usage to enhance the health and performance of livestock animals. The administration of these products plays an important role to enhance cost reduction, feed digestibility, and nutrient absorption, which, in turn, promotes the growth of animals. In addition, various kinds of bacteria such as Lactobacillus and Bifidobacterium are being used in many animal producers.
Major factor that drives the growth of the global direct-fed microbial market include increase in demand for meat & milk consumption. Surge in human population and increase in demand for proteinous diet further boost the market growth. In addition, probiotics aids nutrient absorption by breaking down the complex compounds, which, in turn, helps to reduce the cost of animal production and increases the profitability of the animal producers. However, implementation of stringent regulations regarding the vigorous usage of these microorganisms in animal diet and increase in cost of production are the major factors hampering the market growth. On the contrary, ban on the usage of antibiotics in animal diet in the developed nations such the U.S., Germany, and the UK and rise in animal health concerns are some of the major factors expected to create lucrative opportunities in the near future.
The global direct-fed microbial market is segmented into product type, livestock, and region. By product type, the market is categorized into lactic acid bacteria, Bacillus, and other organisms. Depending on livestock, the market is classified into swine, poultry, ruminants, aquatic animals, and other livestock animals. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as Koninklijke DSM N.V BIO-VET, Archer-Daniels-Midland Company., Chr. Hansen A/S., Biomin Holding GmbH., E. I. DU Pont De Nemours And Company., Novozymes, Kemin Industries, Inc., and Novus International, Inc. are provided in this report.
KEY BENEFITS FOR STAKEHOLDERS
Direct-fed microbial or probiotics are live microorganisms that are beneficial to the gut health. These probiotics are included in the diet of animals to promote their growth and development. In addition, they help to boost the immune system of animals, and thus prevent the growth of pathogenic organisms in the gut. The use of probiotic organisms is replacing antibiotic usage to enhance the health and performance of livestock animals. The administration of these products plays an important role to enhance cost reduction, feed digestibility, and nutrient absorption, which, in turn, promotes the growth of animals. In addition, various kinds of bacteria such as Lactobacillus and Bifidobacterium are being used in many animal producers.
Major factor that drives the growth of the global direct-fed microbial market include increase in demand for meat & milk consumption. Surge in human population and increase in demand for proteinous diet further boost the market growth. In addition, probiotics aids nutrient absorption by breaking down the complex compounds, which, in turn, helps to reduce the cost of animal production and increases the profitability of the animal producers. However, implementation of stringent regulations regarding the vigorous usage of these microorganisms in animal diet and increase in cost of production are the major factors hampering the market growth. On the contrary, ban on the usage of antibiotics in animal diet in the developed nations such the U.S., Germany, and the UK and rise in animal health concerns are some of the major factors expected to create lucrative opportunities in the near future.
The global direct-fed microbial market is segmented into product type, livestock, and region. By product type, the market is categorized into lactic acid bacteria, Bacillus, and other organisms. Depending on livestock, the market is classified into swine, poultry, ruminants, aquatic animals, and other livestock animals. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as Koninklijke DSM N.V BIO-VET, Archer-Daniels-Midland Company., Chr. Hansen A/S., Biomin Holding GmbH., E. I. DU Pont De Nemours And Company., Novozymes, Kemin Industries, Inc., and Novus International, Inc. are provided in this report.
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis along with the current global direct fed microbial market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessments.
- The market size and estimations are based on a comprehensive analysis of key developments in the industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
- By Product Type
- Lactic Acid Bacteria
- Bacillus
- Others
- By Livestock
- Swine
- Poultry
- Ruminants
- Aquatic Animals
- Others
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- List of key players profiled in the report:
- Koninklijke DSM N. V
- BIO-VET
- Archer-Daniels-Midland Company
- CHR. Hansen A/S
- E. I. Du Pont De Nemours And Company
- Novozymes A/S
- Kemin Industries, Inc.
- BASF SE (BASF Corporation)
- Evonik Industries Ag
- Adisseo
- GlaxoSmithKline plc
- Novo Nordisk A/S
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Research methodology
1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Porter's five forces analysis
3.3.Top player positioning
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Surge in demand for meat and milk
3.4.1.2.High need for probiotics to save cost
3.4.2.Restraints
3.4.2.1.Increase in cost of production
3.4.3.Opportunity
3.4.3.1.Rise in concerns regarding the use of antibiotics in animals
CHAPTER 4:DIRECT FED MICROBIAL MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast, by type
4.2.Lactic acid bacteria
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Bacillus
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Others
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:DIRECT FED MICROBIAL MARKET, BY LIVESTOCK
5.1.Overview
5.1.1.Market size and forecast, by livestock
5.2.Swine5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Poultry
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Ruminants
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Aquatic animals
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Others
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
CHAPTER 6:DIRECT FED MICROBIAL MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by type
6.2.3.Market size and forecast, by livestock
6.2.4.Market size and forecast, by country
6.2.4.1.U.S. market size and forecast, by type
6.2.4.2.U.S. market size and forecast, by livestock
6.2.4.3.Canada market size and forecast, by type
6.2.4.4.Canada market size and forecast, by livestock
6.2.4.5.Mexico market size and forecast, by type
6.2.4.6.Mexico market size and forecast, by livestock
6.3.Europe6.3.1.Key market trends and opportunities
6.3.2.Europe market size and forecast, by type
6.3.3.Europe market size and forecast, by livestock
6.3.4.Europe market size and forecast, by country
6.3.4.1.France market size and forecast, by type
6.3.4.2.France market size and forecast, by livestock
6.3.4.3.UK market size and forecast, by type
6.3.4.4.UK market size and forecast, by livestock
6.3.4.5.Germany market size and forecast, by type
6.3.4.6.Germany market size and forecast, by livestock
6.3.4.7.Spain market size and forecast, by type
6.3.4.8.Spain market size and forecast, by livestock
6.3.4.9.Rest of Europe market size and forecast, by type
6.3.4.10.Rest of Europe market size and forecast, by livestock
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Asia-Pacific market size and forecast, by type
6.4.3.Asia-Pacific market size and forecast, by livestock
6.4.4.Asia-Pacific market size and forecast, by country
6.4.4.1.Japan market size and forecast, by type
6.4.4.2.Japan market size and forecast, by livestock
6.4.4.3.China market size and forecast, by type
6.4.4.4.China market size and forecast, by livestock
6.4.4.5.India market size and forecast, by type
6.4.4.6.India market size and forecast, by livestock
6.4.4.7.Australia market size and forecast, by type
6.4.4.8.Australia market size and forecast, by livestock
6.4.4.9.Rest of Asia-Pacific market size and forecast, by type
6.4.4.10.Rest of Asia-Pacific market size and forecast, by livestock
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.LAMEA market size and forecast, by type
6.5.3.LAMEA market size and forecast, by livestock
6.5.4.LAMEA market size and forecast, by country
6.5.4.1.Brazil market size and forecast, by type
6.5.4.2.Brazil market size and forecast, by livestock
6.5.4.3.Saudi Arabia market size and forecast, by type
6.5.4.4.Saudi Arabia market size and forecast, by livestock
6.5.4.5.Rest of LAMEA market size and forecast, by type
6.5.4.6.Rest of LAMEA market size and forecast, by livestock
6.5.4.7.Rest of LAMEA market size and forecast, by end user
CHAPTER 7:COMPANY PROFILES
7.1.ADISSEO
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.2.ARCHER-DANIELS-MIDLAND COMPANY
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.3.BASF SE (BASF Corporation)
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.4.BIO-VET
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.5.CHR. HANSEN A/S
7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Product portfolio
7.5.4.Business performance
7.6.E. I. DU PONT DE NEMOURS AND COMPANY
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.EVONIK INDUSTRIES AG
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.9.KEMIN INDUSTRIES, INC.
7.9.1.Company overview
7.9.2.Operating business segments
7.9.3.Product portfolio
7.10.KONINKLIJKE DSM N. V.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.11.Novozymes A/S
7.11.1.Company overview
7.11.2.Company snapshot
7.11.3.Operating business segments
7.11.4.Product portfolio
7.11.5.Business performance
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Research methodology
1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Porter's five forces analysis
3.3.Top player positioning
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Surge in demand for meat and milk
3.4.1.2.High need for probiotics to save cost
3.4.2.Restraints
3.4.2.1.Increase in cost of production
3.4.3.Opportunity
3.4.3.1.Rise in concerns regarding the use of antibiotics in animals
CHAPTER 4:DIRECT FED MICROBIAL MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast, by type
4.2.Lactic acid bacteria
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Bacillus
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Others
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:DIRECT FED MICROBIAL MARKET, BY LIVESTOCK
5.1.Overview
5.1.1.Market size and forecast, by livestock
5.2.Swine5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Poultry
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Ruminants
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Aquatic animals
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Others
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
CHAPTER 6:DIRECT FED MICROBIAL MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by type
6.2.3.Market size and forecast, by livestock
6.2.4.Market size and forecast, by country
6.2.4.1.U.S. market size and forecast, by type
6.2.4.2.U.S. market size and forecast, by livestock
6.2.4.3.Canada market size and forecast, by type
6.2.4.4.Canada market size and forecast, by livestock
6.2.4.5.Mexico market size and forecast, by type
6.2.4.6.Mexico market size and forecast, by livestock
6.3.Europe6.3.1.Key market trends and opportunities
6.3.2.Europe market size and forecast, by type
6.3.3.Europe market size and forecast, by livestock
6.3.4.Europe market size and forecast, by country
6.3.4.1.France market size and forecast, by type
6.3.4.2.France market size and forecast, by livestock
6.3.4.3.UK market size and forecast, by type
6.3.4.4.UK market size and forecast, by livestock
6.3.4.5.Germany market size and forecast, by type
6.3.4.6.Germany market size and forecast, by livestock
6.3.4.7.Spain market size and forecast, by type
6.3.4.8.Spain market size and forecast, by livestock
6.3.4.9.Rest of Europe market size and forecast, by type
6.3.4.10.Rest of Europe market size and forecast, by livestock
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Asia-Pacific market size and forecast, by type
6.4.3.Asia-Pacific market size and forecast, by livestock
6.4.4.Asia-Pacific market size and forecast, by country
6.4.4.1.Japan market size and forecast, by type
6.4.4.2.Japan market size and forecast, by livestock
6.4.4.3.China market size and forecast, by type
6.4.4.4.China market size and forecast, by livestock
6.4.4.5.India market size and forecast, by type
6.4.4.6.India market size and forecast, by livestock
6.4.4.7.Australia market size and forecast, by type
6.4.4.8.Australia market size and forecast, by livestock
6.4.4.9.Rest of Asia-Pacific market size and forecast, by type
6.4.4.10.Rest of Asia-Pacific market size and forecast, by livestock
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.LAMEA market size and forecast, by type
6.5.3.LAMEA market size and forecast, by livestock
6.5.4.LAMEA market size and forecast, by country
6.5.4.1.Brazil market size and forecast, by type
6.5.4.2.Brazil market size and forecast, by livestock
6.5.4.3.Saudi Arabia market size and forecast, by type
6.5.4.4.Saudi Arabia market size and forecast, by livestock
6.5.4.5.Rest of LAMEA market size and forecast, by type
6.5.4.6.Rest of LAMEA market size and forecast, by livestock
6.5.4.7.Rest of LAMEA market size and forecast, by end user
CHAPTER 7:COMPANY PROFILES
7.1.ADISSEO
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.2.ARCHER-DANIELS-MIDLAND COMPANY
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.3.BASF SE (BASF Corporation)
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.4.BIO-VET
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.5.CHR. HANSEN A/S
7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Product portfolio
7.5.4.Business performance
7.6.E. I. DU PONT DE NEMOURS AND COMPANY
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.EVONIK INDUSTRIES AG
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.9.KEMIN INDUSTRIES, INC.
7.9.1.Company overview
7.9.2.Operating business segments
7.9.3.Product portfolio
7.10.KONINKLIJKE DSM N. V.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.11.Novozymes A/S
7.11.1.Company overview
7.11.2.Company snapshot
7.11.3.Operating business segments
7.11.4.Product portfolio
7.11.5.Business performance
LIST OF TABLES
TABLE 01.GLOBAL DIRECT FED MICROBIAL MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 02.DIRECT FED MICROBIAL MARKET FOR LACTIC ACID BACTERIA, BY REGION, 2018–2026 ($MILLION)
TABLE 03.DIRECT FED MICROBIAL MARKET FOR LACTIC ACID BACTERIA, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 04.DIRECT FED MICROBIAL MARKET FOR BACILLUS SUBTILIS, BY REGION 2018–2026 ($MILLION)
TABLE 05.DIRECT FED MICROBIAL MARKET FOR BACILLUS SUBTILIS, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 06.DIRECT FED MICROBIAL MARKET FOR OTHERS, BY REGION 2018–2026 ($MILLION)
TABLE 07.DIRECT FED MICROBIAL MARKET FOR BACILLUS, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 08.GLOBAL DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 09.DIRECT FED MICROBIAL MARKET FOR SWINE, BY REGION, 2018–2026 ($MILLION)
TABLE 10.DIRECT FED MICROBIAL MARKET FOR POULTRY, BY REGION, 2018–2026 ($MILLION)
TABLE 11.DIRECT FED MICROBIAL MARKET FOR RUMINANTS, BY REGION, 2018–2026 ($MILLION)
TABLE 12.DIRECT FED MICROBIAL MARKET FOR AQUATIC ANIMALS, BY REGION, 2018–2026 ($MILLION)
TABLE 13.DIRECT FED MICROBIAL MARKET FOR OTHER LIVESTOCK ANIMALS, BY REGION, 2018–2026 ($MILLION)
TABLE 14.DIRECT FED MICROBIAL MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 15.NORTH AMERICA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 16.NORTH AMERICA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 17.NORTH AMERICA DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 18.U.S. DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 19.U.S. DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 20.CANADA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 21.CANADA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 22.MEXICO DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 23.MEXICO DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 24.EUROPE DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 25.EUROPE DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 26.EUROPE DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 27.FRANCE DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 28.FRANCE DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 29.UK DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 30.UK DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 31.GERMANY DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 32.GERMANY DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 33.SPAIN DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 34.SPAIN DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 35.REST OF EUROPE DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 36.REST OF EUROPE DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 37.ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 38.ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 39.ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 40.JAPAN DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 41.JAPAN DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 42.CHINA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 43.CHINA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 44.INDIA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 45.INDIA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 46.AUSTRALIA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 47.AUSTRALIA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 48.REST OF ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 49.REST OF ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 50.LAMEA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 51.LAMEA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 52.LAMEA DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 53.BRAZIL DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 54.BRAZIL DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 55.SAUDI ARABIA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 56.SAUDI ARABIA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 57.REST OF LAMEA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 58.REST OF LAMEA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 59.REST OF LAMEA DIRECT FED MICROBIAL MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 60.ADISSEO: COMPANY SNAPSHOT
TABLE 61.SUZHOU ZHONGJING LIFE & SCIENCE TECHNOLOGY CO., LTD: PRODUCT PORTFOLIO
TABLE 62.ARCHER DANIELS: COMPANY SNAPSHOT
TABLE 63.ARCHER DANIELS: OPERATING SEGMENTS
TABLE 64.ARCHER DANIELS: PRODUCT PORTFOLIO
TABLE 65.BASF: COMPANY SNAPSHOT
TABLE 66.BASF: OPERATING SEGMENTS
TABLE 67.BASF: PRODUCT PORTFOLIO
TABLE 68.BIO-VET: COMPANY SNAPSHOT
TABLE 69.BIO-VET: PRODUCT PORTFOLIO
TABLE 70.CHR. HANSEN.: COMPANY SNAPSHOT
TABLE 71.CHR. HANSEN.: OPERATING SEGMENTS
TABLE 72.CHR. HANSEN.: PRODUCT PORTFOLIO
TABLE 73.DUPONT: COMPANY SNAPSHOT
TABLE 74.DUPONT: OPERATING SEGMENTS
TABLE 75.DUPONT: PRODUCT PORTFOLIO
TABLE 76.EVONIK.: COMPANY SNAPSHOT
TABLE 77.EVONIK.: PRODUCT PORTFOLIO
TABLE 78.KEMIN: COMPANY SNAPSHOT
TABLE 79.KEMIN: PRODUCT PORTFOLIO
TABLE 80.KONINKLIJKE DSM: COMPANY SNAPSHOT
TABLE 81.KONINKLIJKE DSM: OPERATING SEGMENTS
TABLE 82.KONINKLIJKE DSM: PRODUCT PORTFOLIO
TABLE 83.NOVOZYMES A/S: COMPANY SNAPSHOT
TABLE 84.NOVOZYMES A/S: PRODUCT CATEGORIES
TABLE 85.NOVOZYMES A/S: PRODUCT PORTFOLIO
TABLE 01.GLOBAL DIRECT FED MICROBIAL MARKET, BY PRODUCT TYPE, 2018–2026 ($MILLION)
TABLE 02.DIRECT FED MICROBIAL MARKET FOR LACTIC ACID BACTERIA, BY REGION, 2018–2026 ($MILLION)
TABLE 03.DIRECT FED MICROBIAL MARKET FOR LACTIC ACID BACTERIA, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 04.DIRECT FED MICROBIAL MARKET FOR BACILLUS SUBTILIS, BY REGION 2018–2026 ($MILLION)
TABLE 05.DIRECT FED MICROBIAL MARKET FOR BACILLUS SUBTILIS, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 06.DIRECT FED MICROBIAL MARKET FOR OTHERS, BY REGION 2018–2026 ($MILLION)
TABLE 07.DIRECT FED MICROBIAL MARKET FOR BACILLUS, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 08.GLOBAL DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 09.DIRECT FED MICROBIAL MARKET FOR SWINE, BY REGION, 2018–2026 ($MILLION)
TABLE 10.DIRECT FED MICROBIAL MARKET FOR POULTRY, BY REGION, 2018–2026 ($MILLION)
TABLE 11.DIRECT FED MICROBIAL MARKET FOR RUMINANTS, BY REGION, 2018–2026 ($MILLION)
TABLE 12.DIRECT FED MICROBIAL MARKET FOR AQUATIC ANIMALS, BY REGION, 2018–2026 ($MILLION)
TABLE 13.DIRECT FED MICROBIAL MARKET FOR OTHER LIVESTOCK ANIMALS, BY REGION, 2018–2026 ($MILLION)
TABLE 14.DIRECT FED MICROBIAL MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 15.NORTH AMERICA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 16.NORTH AMERICA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 17.NORTH AMERICA DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 18.U.S. DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 19.U.S. DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 20.CANADA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 21.CANADA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 22.MEXICO DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 23.MEXICO DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 24.EUROPE DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 25.EUROPE DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 26.EUROPE DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 27.FRANCE DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 28.FRANCE DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 29.UK DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 30.UK DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 31.GERMANY DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 32.GERMANY DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 33.SPAIN DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 34.SPAIN DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 35.REST OF EUROPE DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 36.REST OF EUROPE DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 37.ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 38.ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 39.ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 40.JAPAN DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 41.JAPAN DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 42.CHINA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 43.CHINA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 44.INDIA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 45.INDIA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 46.AUSTRALIA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 47.AUSTRALIA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 48.REST OF ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 49.REST OF ASIA-PACIFIC DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 50.LAMEA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 51.LAMEA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 52.LAMEA DIRECT FED MICROBIAL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 53.BRAZIL DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 54.BRAZIL DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 55.SAUDI ARABIA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 56.SAUDI ARABIA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 57.REST OF LAMEA DIRECT FED MICROBIAL MARKET, BY TYPE, 2018–2026 ($MILLION)
TABLE 58.REST OF LAMEA DIRECT FED MICROBIAL MARKET, BY LIVESTOCK, 2018–2026 ($MILLION)
TABLE 59.REST OF LAMEA DIRECT FED MICROBIAL MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 60.ADISSEO: COMPANY SNAPSHOT
TABLE 61.SUZHOU ZHONGJING LIFE & SCIENCE TECHNOLOGY CO., LTD: PRODUCT PORTFOLIO
TABLE 62.ARCHER DANIELS: COMPANY SNAPSHOT
TABLE 63.ARCHER DANIELS: OPERATING SEGMENTS
TABLE 64.ARCHER DANIELS: PRODUCT PORTFOLIO
TABLE 65.BASF: COMPANY SNAPSHOT
TABLE 66.BASF: OPERATING SEGMENTS
TABLE 67.BASF: PRODUCT PORTFOLIO
TABLE 68.BIO-VET: COMPANY SNAPSHOT
TABLE 69.BIO-VET: PRODUCT PORTFOLIO
TABLE 70.CHR. HANSEN.: COMPANY SNAPSHOT
TABLE 71.CHR. HANSEN.: OPERATING SEGMENTS
TABLE 72.CHR. HANSEN.: PRODUCT PORTFOLIO
TABLE 73.DUPONT: COMPANY SNAPSHOT
TABLE 74.DUPONT: OPERATING SEGMENTS
TABLE 75.DUPONT: PRODUCT PORTFOLIO
TABLE 76.EVONIK.: COMPANY SNAPSHOT
TABLE 77.EVONIK.: PRODUCT PORTFOLIO
TABLE 78.KEMIN: COMPANY SNAPSHOT
TABLE 79.KEMIN: PRODUCT PORTFOLIO
TABLE 80.KONINKLIJKE DSM: COMPANY SNAPSHOT
TABLE 81.KONINKLIJKE DSM: OPERATING SEGMENTS
TABLE 82.KONINKLIJKE DSM: PRODUCT PORTFOLIO
TABLE 83.NOVOZYMES A/S: COMPANY SNAPSHOT
TABLE 84.NOVOZYMES A/S: PRODUCT CATEGORIES
TABLE 85.NOVOZYMES A/S: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL DIRECT FED MICROBIAL MARKET SEGMENTATION
FIGURE 02.HIGH-TO-MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.LOW THREAT OF SUBSTITUTES
FIGURE 05.LOW THREAT OF NEW ENTRANTS
FIGURE 06.HIGH COMPETITIVE RIVALARY
FIGURE 07.TOP PLAYER POSITIONING, 2018
FIGURE 08.DRIVERS AND RESTRAINTS
FIGURE 09.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR SWINE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR POULTRY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR RUMINANTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR AQUATIC ANIMALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14.BASF: NET SALES, 2016–2018 ($MILLION)
FIGURE 15.BASF: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 16.BASF: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 17.CHR. HANSEN: NET SALES, 2017–2018 ($MILLION)
FIGURE 18.CHR. HANSEN: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 19.CHR. HANSEN: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 20.NET SALES, 2016–2018 ($MILLION)
FIGURE 21.DUPONT: NET SALES BY DIVISION, 2018 (%)
FIGURE 22.DUPONT: NET SALES BY REGION, 2018 (%)
FIGURE 23.KONINKLIJKE DSM: NET SALES, 2017–2018 ($MILLION)
FIGURE 24.KONINKLIJKE DSM: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 25.KONINKLIJKE DSM: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 26.NOVOZYMES A/S: REVENUE, 2016–2018 ($MILLION)
FIGURE 27.NOVOZYMES A/S: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 28.NOVOZYMES A/S: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 01.GLOBAL DIRECT FED MICROBIAL MARKET SEGMENTATION
FIGURE 02.HIGH-TO-MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.LOW THREAT OF SUBSTITUTES
FIGURE 05.LOW THREAT OF NEW ENTRANTS
FIGURE 06.HIGH COMPETITIVE RIVALARY
FIGURE 07.TOP PLAYER POSITIONING, 2018
FIGURE 08.DRIVERS AND RESTRAINTS
FIGURE 09.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR SWINE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR POULTRY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR RUMINANTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR AQUATIC ANIMALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIRECT FED MICROBIAL MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14.BASF: NET SALES, 2016–2018 ($MILLION)
FIGURE 15.BASF: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 16.BASF: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 17.CHR. HANSEN: NET SALES, 2017–2018 ($MILLION)
FIGURE 18.CHR. HANSEN: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 19.CHR. HANSEN: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 20.NET SALES, 2016–2018 ($MILLION)
FIGURE 21.DUPONT: NET SALES BY DIVISION, 2018 (%)
FIGURE 22.DUPONT: NET SALES BY REGION, 2018 (%)
FIGURE 23.KONINKLIJKE DSM: NET SALES, 2017–2018 ($MILLION)
FIGURE 24.KONINKLIJKE DSM: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 25.KONINKLIJKE DSM: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 26.NOVOZYMES A/S: REVENUE, 2016–2018 ($MILLION)
FIGURE 27.NOVOZYMES A/S: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 28.NOVOZYMES A/S: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
